Contrast-enhanced Spectral Mammography Without and with a Delayed Image for Diagnosing Malignancy Among Mass Lesions in Dense Breast
Overview
Authors
Affiliations
Aim Of The Study: To analyse the diagnostic performance of contrast-enhanced spectral mammography (CESM) based on morphologic and enhancement patterns of mass lesions in dense breast using different protocols: CESM without delayed image and CESM with delayed image.
Material And Methods: A total of 151 informed women with suspicious for malignancy mass lesions in dense breast were included in this study. All of them underwent CESM using 2 protocols. A total of 155 lesions were pathomorphologically verified. We analysed morphologic patterns on low-energy (LE) images and recombined images (RI) by defining the shape, margin, and dynamic patterns based on delayed images.
Results: The comparative analysis revealed that the shape and margins on RI were more significant than those on LE images. The dynamic indicators of CESM were found to be highly significant in dense breasts. The correlation between kinetic curve and histological results demonstrated that a persistent type of curve was common for benign lesions, accounting for 15/22 (68.1%); plateau and washout - for malignant lesions, accounting for 24/89 (26.9%) and 61/89 (68.5%), respectively. Delayed image leads to an increase of specificity up to 12.4%, which is statistically significant. The area under the curve (AUC) in CESM with delayed image is larger than that in CESM without delayed image ( < 0.01).
Conclusions: CESM is sensitive for the differential diagnosis of breast lesions. CESM with delayed image has higher specificity than CESM without delayed image. Delayed images with plateau and washout are typical for malignancy.
Filippone F, Boudagga Z, Frattini F, Fortuna G, Razzini D, Tambasco A Diagnostics (Basel). 2024; 14(21).
PMID: 39518367 PMC: 11545212. DOI: 10.3390/diagnostics14212400.
Contrast-enhanced mammography improves patient access to functional breast imaging.
Taylor D, Kessell M, Parizel P J Med Imaging Radiat Oncol. 2024; 69(1):46-61.
PMID: 39482841 PMC: 11834761. DOI: 10.1111/1754-9485.13789.
Rong X, Kang Y, Li Y, Xue J, Li Z, Yang G Quant Imaging Med Surg. 2024; 14(8):5541-5554.
PMID: 39144044 PMC: 11320531. DOI: 10.21037/qims-24-593.
Lin S, Li H, Li Y, Chen Q, Ye J, Lin S Cancer Med. 2024; 13(8):e7128.
PMID: 38659408 PMC: 11043676. DOI: 10.1002/cam4.7128.
Klaric K, Sribar A, Budisavljevic A, Labinac L, Valkovic Zujic P Diagnostics (Basel). 2023; 13(11).
PMID: 37296810 PMC: 10252621. DOI: 10.3390/diagnostics13111958.